Group One Trading
ONCT

Group One Trading’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Group One Trading’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,075
Closed -$24K – 8475
2022
Q2 		$24K Hold
1,075
– – ﹤0.01% 6161
2022
Q1 		$30K Buy
1,075
+450
+72% +$16.4K ﹤0.01% 6489
2021
Q4 		$28K Buy
625
+125
+25% +$8.41K ﹤0.01% 6772
2021
Q3 		$42K Sell
500
-1,750
-78% -$145K ﹤0.01% 6684
2021
Q2 		$214K Buy
2,250
+2,050
+1,025% +$243K ﹤0.01% 5181
2021
Q1 		$33K Buy
+200
New +$26.5K ﹤0.01% 6493
2019
Q2 		– Sell
-7
Closed -$1K – 5515
2019
Q1 		$1K Hold
7
– – ﹤0.01% 4683
2018
Q4 		$1K Buy
7
+1
+17% +$200 ﹤0.01% 4760
2018
Q3 		$1K Buy
+6
New +$14.4K ﹤0.01% 5093
2015
Q1 		– Sell
-3
Closed -$3K – 5302
2014
Q4 		$3K Sell
3
-9
-75% -$8.03K ﹤0.01% 4629
2014
Q3 		$12K Sell
12
-1
-8% -$1.47K ﹤0.01% 4391
2014
Q2 		$24K Sell
13
-34
-72% -$67.3K ﹤0.01% 4049
2014
Q1 		$101K Buy
47
+6
+15% +$14.9K ﹤0.01% 3078
2013
Q4 		$96K Sell
41
-55
-57% -$126K ﹤0.01% 3077
2013
Q3 		$271K Buy
96
+79
+465% +$393K 0.01% 2121
2013
Q2 		$158K Buy
+17
New +$131K ﹤0.01% 2389

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $324M AUM 37.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Group One Trading's ONCT Position: Q3 2022 in Review

Group One Trading sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q3 2022, closing a stake of 1,040 shares — an estimated $22.3K sold.

Group One Trading first reported a position in ONCT in Q1 2014 and held it in 20 quarters. The position peaked at $214K in Q1 2021. 61 funds tracked by Wall St. Rank hold ONCT as of Q3 2022.

  • Group One Trading reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Group One Trading sold 1,040 Oncternal Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $22.3K.
  • Group One Trading first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q1 2014 and held it in 20 quarters.
  • Group One Trading's Oncternal Therapeutics, Inc. Common Stock position peaked at $214K in Q1 2021.
  • 61 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Group One Trading's 13F filing for Q3 2022, filed 9 Nov 2022.